These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1050 related articles for article (PubMed ID: 26144101)
1. National Trends in Ambulatory Oral Anticoagulant Use. Barnes GD; Lucas E; Alexander GC; Goldberger ZD Am J Med; 2015 Dec; 128(12):1300-5.e2. PubMed ID: 26144101 [TBL] [Abstract][Full Text] [Related]
2. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E Eur J Clin Pharmacol; 2017 Nov; 73(11):1417-1425. PubMed ID: 28735494 [TBL] [Abstract][Full Text] [Related]
3. Trends in anticoagulant prescribing: a review of local policies in English primary care. Ho KH; van Hove M; Leng G BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380 [TBL] [Abstract][Full Text] [Related]
4. National trends in oral anticoagulant use in the United States, 2007 to 2011. Kirley K; Qato DM; Kornfield R; Stafford RS; Alexander GC Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):615-21. PubMed ID: 22949490 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients. Kalani C; Awudi E; Alexander T; Udeani G; Surani S Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732 [No Abstract] [Full Text] [Related]
6. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255 [TBL] [Abstract][Full Text] [Related]
7. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh EA; Chalmers L; Bereznicki LR Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063 [TBL] [Abstract][Full Text] [Related]
12. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation. Kido K; Ngorsuraches S Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States. Baker CL; Dhamane AD; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Menges B; Lin J; Nadkarni A Adv Ther; 2019 Jan; 36(1):162-174. PubMed ID: 30499067 [TBL] [Abstract][Full Text] [Related]
14. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US. Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203 [TBL] [Abstract][Full Text] [Related]
15. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials. Loffredo L; Perri L; Violi F Dig Liver Dis; 2015 May; 47(5):429-31. PubMed ID: 25732432 [TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013. Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181 [TBL] [Abstract][Full Text] [Related]
17. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of anticoagulation selection for acute venous thromboembolism. Badreldin H; Nichols H; Rimsans J; Carter D J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341 [TBL] [Abstract][Full Text] [Related]
19. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation]. Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H Therapie; 2015; 70(6):485-92. PubMed ID: 26223162 [TBL] [Abstract][Full Text] [Related]
20. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation. Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]